http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27559059

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1676
issn 1860-7179
1860-7187
issueIdentifier 10
pageRange 1673-1676
publicationName ChemMedChem
startingPage 1673
bibliographicCitation Behrendt CT, Kunfermann A, Illarionova V, Matheeussen A, Gräwert T, Groll M, Rohdich F, Bacher A, Eisenreich W, Fischer M, Maes L, Kurz T. Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin. ChemMedChem. 2010 Oct 04;5(10):1673–6. doi: 10.1002/cmdc.201000276. PMID: 20718073.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_674d809be54dc086b701544bca837445
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0779f4be607a31e418f976b3582533e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be947ae2b8b217cb82c063cd76870f80
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_728c3e749f29a158e248f5e5cb84bd3d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f793a89367caa4a41960286aa9e859a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32870881cbac799ec4569ee871cc47c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_669b1383f592cf97553fc7cee307587e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1bcc4ab287cd8309e6e651742f6e027
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df1388576160c1902ee9d19abfc488a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fe94b1cb5b7a5bcc087e377a840465d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5e9326492ff3376b261044e1f99bee0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_080be1b6256dc671c266427445f900a9
date 2010-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20718073
https://doi.org/10.1002/cmdc.201000276
isPartOf https://portal.issn.org/resource/ISSN/1860-7187
https://portal.issn.org/resource/ISSN/1860-7179
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33017
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Synthesis and Antiplasmodial Activity of Highly Active Reverse Analogues of the Antimalarial Drug Candidate Fosmidomycin
discusses http://id.nlm.nih.gov/mesh/M0083078
http://id.nlm.nih.gov/mesh/M0015649
http://id.nlm.nih.gov/mesh/M0008779
http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0010739
http://id.nlm.nih.gov/mesh/M0001469
http://id.nlm.nih.gov/mesh/M0014188
http://id.nlm.nih.gov/mesh/M0029314
http://id.nlm.nih.gov/mesh/M0294689
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010088Q000037
http://id.nlm.nih.gov/mesh/D009097Q000037
http://id.nlm.nih.gov/mesh/D000962Q000138
http://id.nlm.nih.gov/mesh/D019747Q000037
http://id.nlm.nih.gov/mesh/D005578Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011994Q000235
http://id.nlm.nih.gov/mesh/D010088Q000378
http://id.nlm.nih.gov/mesh/D010963Q000201
http://id.nlm.nih.gov/mesh/D010088Q000235
http://id.nlm.nih.gov/mesh/D000962Q000494
http://id.nlm.nih.gov/mesh/D009097Q000378
http://id.nlm.nih.gov/mesh/D009097Q000235
http://id.nlm.nih.gov/mesh/D019747Q000235
http://id.nlm.nih.gov/mesh/D019747Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005578Q000737
http://id.nlm.nih.gov/mesh/D000962Q000737
http://id.nlm.nih.gov/mesh/D011994Q000037
http://id.nlm.nih.gov/mesh/D005578Q000494
http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D006877Q000737
http://id.nlm.nih.gov/mesh/D011994Q000378
http://id.nlm.nih.gov/mesh/D004926Q000201
http://id.nlm.nih.gov/mesh/D005578Q000138

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223707497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223711020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID635741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127964616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223709929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163676260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163657007

Total number of triples: 72.